Pharmaniaga Berhad (KLSE:PHARMA)
0.235
0.00 (0.00%)
At close: Dec 5, 2025
Pharmaniaga Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,541 | 512 | 555 | 714 | 969 | 1,309 | Upgrade
|
| Market Cap Growth | 192.92% | -7.79% | -22.28% | -26.35% | -25.92% | 143.16% | Upgrade
|
| Enterprise Value | 2,213 | 1,709 | 1,690 | 1,800 | 1,749 | 2,023 | Upgrade
|
| Last Close Price | 0.23 | 0.21 | 0.23 | 0.32 | 0.40 | 0.51 | Upgrade
|
| PE Ratio | 12.67 | 3.88 | - | - | 5.63 | 47.60 | Upgrade
|
| Forward PE | 27.65 | 10.60 | 24.06 | 11.24 | 11.53 | 20.20 | Upgrade
|
| PS Ratio | 0.39 | 0.14 | 0.16 | 0.21 | 0.20 | 0.48 | Upgrade
|
| PB Ratio | 3.42 | -3.51 | -2.02 | -2.05 | 2.06 | 3.69 | Upgrade
|
| P/TBV Ratio | 5.55 | - | - | - | 3.95 | 9.63 | Upgrade
|
| P/FCF Ratio | - | 44.46 | - | - | - | - | Upgrade
|
| P/OCF Ratio | - | 11.99 | 11.82 | - | - | - | Upgrade
|
| PEG Ratio | - | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | Upgrade
|
| EV/Sales Ratio | 0.57 | 0.45 | 0.50 | 0.52 | 0.36 | 0.74 | Upgrade
|
| EV/EBITDA Ratio | 13.06 | 5.92 | 229.97 | 32.36 | 5.22 | 21.42 | Upgrade
|
| EV/EBIT Ratio | 16.22 | 6.55 | - | 64.27 | 5.69 | 29.93 | Upgrade
|
| EV/FCF Ratio | -56.31 | 148.48 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 2.21 | -8.17 | -4.35 | -3.35 | 1.82 | 1.89 | Upgrade
|
| Debt / EBITDA Ratio | 5.86 | 3.98 | 65.02 | 18.83 | 2.53 | 6.83 | Upgrade
|
| Debt / FCF Ratio | - | 103.57 | - | - | - | - | Upgrade
|
| Asset Turnover | 1.72 | 1.92 | 1.81 | 1.70 | 2.51 | 1.72 | Upgrade
|
| Inventory Turnover | 5.71 | 5.39 | 4.60 | 3.09 | 4.52 | 4.03 | Upgrade
|
| Quick Ratio | 0.57 | 0.29 | 0.24 | 0.19 | 0.22 | 0.27 | Upgrade
|
| Current Ratio | 0.92 | 0.62 | 0.55 | 0.58 | 1.11 | 0.78 | Upgrade
|
| Return on Equity (ROE) | 29.63% | - | - | -1027.82% | 41.73% | 7.38% | Upgrade
|
| Return on Assets (ROA) | 3.76% | 8.35% | -0.68% | 0.85% | 10.01% | 2.66% | Upgrade
|
| Return on Capital (ROIC) | 6.74% | 16.61% | -1.47% | 1.63% | 16.32% | 4.33% | Upgrade
|
| Return on Capital Employed (ROCE) | 21.40% | 665.10% | 23.30% | -12.70% | 38.90% | 17.50% | Upgrade
|
| Earnings Yield | 2.80% | 25.77% | -14.45% | -88.23% | 17.76% | 2.10% | Upgrade
|
| FCF Yield | -2.55% | 2.25% | -0.67% | -28.24% | -9.74% | -2.67% | Upgrade
|
| Dividend Yield | - | - | - | 5.86% | 23.18% | 4.27% | Upgrade
|
| Payout Ratio | - | - | - | - | 34.24% | 95.10% | Upgrade
|
| Buyback Yield / Dilution | -61.41% | -5.38% | -4.40% | -0.05% | -0.04% | -0.33% | Upgrade
|
| Total Shareholder Return | -61.41% | -5.38% | -4.40% | 5.82% | 23.14% | 3.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.